Pathlight™, a personalized, tumor-informed molecular residual disease (MRD) platform, will expand Foundation Medicine’s testing capabilities Pathlight uses a proprietary combination of whole genome ...

Nearly a year after the first U.S. commercial launch of the multicancer molecular residual disease (MRD) detection platform Pathlight, developer Saga Diagnostics entered a definitive merger agreement ...

Mathematician Kevin Buzzard of Imperial College London is training computers how to prove one of the most famous problems in math history: Fermat’s last theorem. Resolving the problem isn’t the point.

Preemptive azacitidine treatment guided by measurable residual disease (MRD) status was associated with delayed relapse in patients with myelodysplastic neoplasms or acute myeloid leukemia (AML), with ...

Even when patients with acute myeloid leukemia (AML) appear to be in remission, small numbers of cancer cells can remain in the body. These lingering cells—known as measurable residual disease ...

Axiom Math is giving away a powerful new AI tool. But it remains to be seen if it speeds up research as much as the company hopes. Axiom Math, a startup based in Palo Alto, California, has released a ...

GRANVILLE, Ohio (WCMH) — It was a dream weekend for Denison University in Granville after the school won two national championships in one day. “We always knew that we had this potential and it was ...

The Denison men’s swim team won its seventh national title, repeating for the third time in its storied history under legendary coach Gregg Parini. Nick Fogle, George Goins and Jack Hill each won two ...

The Denison women’s basketball team completed a dream season March 21 and left no doubt. Denison beat No. 2 Scranton 55-41, using a dominant 22-7 edge in the fourth quarter, to win its first NCAA ...

Dr. Ajay K. Nooka, highlights how the evolution of therapy has moved the goalposts from simply achieving remission to pursuing a measurable cure. In the rapidly shifting landscape of multiple myeloma ...

Rapid Novor Inc., a Canadian biotechnology leader, announced today that its diagnostic laboratory has received a provisional license from the Ontario Ministry of Health (MOH) for its EasyM ® assay, ...